InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Reicin Alise, Chief Executive Officer. Insider active across 1 company, notably Tectonic Therapeutic, Inc.. Aggregated, 10 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €89k. Activity tracked since 4 December 2024. The latest transaction was filed on 4 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Reicin Alise
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
76,500 shares0Common StockSEC:0001757533-26-000009:0
2,500 shares@ US$21.100.0084% mcap50.0% of flowCommon StockSEC:0001757533-26-000008:0
Canonical exit: 12 May 2026 (T+90)
2,500 shares@ US$21.1021.5% of flowCommon StockSEC:0001757533-26-000005:0
Canonical exit: 12 May 2026 (T+90)
4,104 shares@ US$23.2239.1% of flowCommon StockSEC:0001757533-26-000004:0
10,966 shares@ US$2.3810.8% of flowCommon StockSEC:0001757533-26-000002:0
14,700 shares0Common StockSEC:0001757533-25-000004:0
859 shares@ US$19.8125.0% of flowCommon StockSEC:0001415889-25-018106:0
36,047 shares0Common StockSEC:0001415889-25-003225:0
11,717 shares0Common StockSEC:0001415889-24-028516:0
166,580 sharesCommon StockSEC:0001415889-24-017952:0
10 of 10 declarations
About Reicin Alise
Alise Reicin is the Chief Executive Officer of Tectonic Therapeutic, Inc. She oversees the strategic and operational direction of the company, ensuring it achieves its growth objectives. Reicin brings extensive experience in the biopharmaceutical sector.
